Information Journal Paper
APA:
CopyWEN, J.. (2015). ACTIVATION OF CB2 RECEPTOR IS REQUIRED FOR THE THERAPEUTIC EFFECT OF ABHD6 INHIBITION IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS. NEUROPHARMACOLOGY, 99(-), 0-0. SID. https://sid.ir/paper/714872/en
Vancouver:
CopyWEN J.. ACTIVATION OF CB2 RECEPTOR IS REQUIRED FOR THE THERAPEUTIC EFFECT OF ABHD6 INHIBITION IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS. NEUROPHARMACOLOGY[Internet]. 2015;99(-):0-0. Available from: https://sid.ir/paper/714872/en
IEEE:
CopyJ. WEN, “ACTIVATION OF CB2 RECEPTOR IS REQUIRED FOR THE THERAPEUTIC EFFECT OF ABHD6 INHIBITION IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS,” NEUROPHARMACOLOGY, vol. 99, no. -, pp. 0–0, 2015, [Online]. Available: https://sid.ir/paper/714872/en